| Queencell (Anterogen Co. Ltd.) |
South Korea (2010) |
Subcutaneous tissue defects |
Autologous human AT-MSC |
| Cellgram-AMI (Pharmicell Co. Ltd.) |
South Korea (2011) |
Acute myocardial infarction |
Autologous human BM-MSC |
| Cartistem (Medipost Co. Ltd.) |
South Korea (2012) |
Knee articular cartilage defects |
Allogeneic human UC-MSC |
| Cupistem (Anterogen Co. Ltd.) |
South Korea (2012) |
Crohn's fistula |
Autologous human BM-MSC |
| Prochymal, remestemcel-L (Osiris Therapeutics Inc., Mesoblast Ltd.) |
Canada (2012) |
GvHD |
Allogeneic human BM-MSC |
|
New Zealand (2012) |
|
|
| Neuronata-R (Corestem Inc.) |
South Korea (2014) |
Amyotrophic lateral sclerosis |
Autologous human BM-MSC |
| Temcell HS (JCR Pharmaceuticals) |
Japan (2015) |
GvHD |
Allogeneic human BM-MSC |
| Stempeucel (Stempeutics Research PVT) |
India (2016) |
Critical limb ischemia |
Allogeneic human BM-MSC |
| Alofisel (TiGenix NV/Takeda) |
Europe (2018) |
Complex perianal fistulas in Crohn's disease |
Allogeneic human AT-MSC |
| Stemirac (Nipro Corp) |
Japan (2018) |
Spinal cord injury |
Autologous human BM-MSC |
